The Cannabist Company is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. The Cannabist Company operates 130 facilities including 99 dispensaries and 31 cultivation and manufacturing facilities, including those under development. The Cannabist Company is one of the original providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets.
In the USA The Cannabist Company has developed significant experience in supplying specialist medicinal products made from cannabis plants and CBD based wellbeing products. In Europe, and the rest of the world, The Cannabist Company focus is on the provision of specialist medicinal products to healthcare professionals, and their The Cannabist Company Platinum CBD wellbeing brand.
Since founded in 2012, The Cannabist Company has supplied products in response to more than thirty million requests and hold one of the largest specialist registries in the world within their product category – the IMPACT Registry™. Their IMPACT Registry™ data describes data in many conditions and allows them to help lead the thinking for potential medicinal utility for cannabis plant derived therapies. The Cannabist Company also provide reports and analyses from the IMPACT Registry™ database that can help healthcare providers optimize their practice.
In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils, and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Plant Sugar, Press, Amber and Platinum Label CBD.